ATE314648T1 - Diagnostisches verfahren für asthma - Google Patents

Diagnostisches verfahren für asthma

Info

Publication number
ATE314648T1
ATE314648T1 AT00908730T AT00908730T ATE314648T1 AT E314648 T1 ATE314648 T1 AT E314648T1 AT 00908730 T AT00908730 T AT 00908730T AT 00908730 T AT00908730 T AT 00908730T AT E314648 T1 ATE314648 T1 AT E314648T1
Authority
AT
Austria
Prior art keywords
test subject
asthma
diagnostic
bodily
sample
Prior art date
Application number
AT00908730T
Other languages
English (en)
Inventor
Stan Hazen
Weikia Wu
David Schmitt
Original Assignee
Cleveland Clinic Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cleveland Clinic Foundation filed Critical Cleveland Clinic Foundation
Application granted granted Critical
Publication of ATE314648T1 publication Critical patent/ATE314648T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00908730T 1999-02-19 2000-02-18 Diagnostisches verfahren für asthma ATE314648T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/253,380 US6306576B1 (en) 1999-02-19 1999-02-19 Diagnostic methods for asthma
PCT/US2000/004253 WO2000049411A1 (en) 1999-02-19 2000-02-18 Diagnostic methods for asthma

Publications (1)

Publication Number Publication Date
ATE314648T1 true ATE314648T1 (de) 2006-01-15

Family

ID=22960028

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00908730T ATE314648T1 (de) 1999-02-19 2000-02-18 Diagnostisches verfahren für asthma

Country Status (5)

Country Link
US (3) US6306576B1 (de)
EP (1) EP1159614B1 (de)
AT (1) ATE314648T1 (de)
DE (1) DE60025170T2 (de)
WO (1) WO2000049411A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020034819A1 (en) * 1998-02-23 2002-03-21 Alan K. Smith Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
US6306576B1 (en) * 1999-02-19 2001-10-23 Cleveland Clinic Foundation Diagnostic methods for asthma
GB0113188D0 (en) * 2001-05-31 2001-07-25 Osmetech Plc Method for detecting conditions
US6939716B2 (en) * 2001-09-19 2005-09-06 Washington University Method for detecting conditions indicative of sepsis
US20110201947A1 (en) * 2008-03-14 2011-08-18 The Cleveland Clinic Foundation Oxidized paraoxonase 1 and paraoxonase 1/hdl particle number ratio as risk markers for cardiovascular disease
EP2353010B1 (de) 2008-10-28 2015-07-08 Uladzimir A. Murauski Verfahren zum nachweis einer toxämie
US9546220B2 (en) 2010-10-19 2017-01-17 Battelle Memorial Institute Compositions, antibodies, asthma diagnosis methods, and methods for preparing antibodies
JP6046053B2 (ja) 2011-01-13 2016-12-14 エクスプレッション、パソロジー、インコーポレイテッドＥｘｐｒｅｓｓｉｏｎ Ｐａｔｈｏｌｏｇｙ， Ｉｎｃ． Ｂｃｌ−２様タンパク質１１のＳＲＭ／ＭＲＭアッセイ
RU2460456C1 (ru) * 2011-02-22 2012-09-10 Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ДПО НГИУВ Минздравсоцразвития России) Способ диагностики обструктивных нарушений проходимости дыхательных путей у пациентов, находящихся на аппаратном дыхании
WO2013124325A1 (en) 2012-02-20 2013-08-29 Murauski Uladzimir A Methods and kits for detection of active malignancy
US11249091B2 (en) 2018-02-22 2022-02-15 The Cleveland Clinic Foundation Detection of glucuronidated and 3-bromotyrosine
CN114324703B (zh) * 2021-12-27 2022-08-30 杭州朱养心药业有限公司 一种同时检测多种氨基酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1008594A (en) * 1963-07-03 1965-10-27 Nat Res Dev Process for the production of amines
US5280788A (en) * 1991-02-26 1994-01-25 Massachusetts Institute Of Technology Devices and methods for optical diagnosis of tissue
SE9300012D0 (sv) * 1993-01-05 1993-01-05 Astra Ab New peptides
US6096513A (en) * 1993-05-20 2000-08-01 Arch Development Corporation Polynucleotides encoding KAPPA opiod receptors
US5953477A (en) * 1995-11-20 1999-09-14 Visionex, Inc. Method and apparatus for improved fiber optic light management
US5773835A (en) * 1996-06-07 1998-06-30 Rare Earth Medical, Inc. Fiber optic spectroscopy
US5710248A (en) * 1996-07-29 1998-01-20 University Of Iowa Research Foundation Peptide tag for immunodetection and immunopurification
US6268220B1 (en) 1996-09-09 2001-07-31 Washington University Diagnostic method for atherosclerosis
US6306576B1 (en) * 1999-02-19 2001-10-23 Cleveland Clinic Foundation Diagnostic methods for asthma
US6758824B1 (en) * 2000-11-06 2004-07-06 Suros Surgical Systems, Inc. Biopsy apparatus

Also Published As

Publication number Publication date
WO2000049411A1 (en) 2000-08-24
US6306576B1 (en) 2001-10-23
EP1159614A4 (de) 2002-03-27
DE60025170D1 (de) 2006-02-02
EP1159614B1 (de) 2005-12-28
US20050142626A1 (en) 2005-06-30
US20020048775A1 (en) 2002-04-25
DE60025170T2 (de) 2006-08-10
EP1159614A1 (de) 2001-12-05

Similar Documents

Publication Publication Date Title
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
JP5873804B2 (ja) 上皮成長因子受容体（ｅｇｆｒ）タンパク質ｓｒｍ／ｍｒｍアッセイ
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
JPH06201704A (ja) Ｈｄｌコレステロールに関する全血アッセイの改良型試験具および方法
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
DE69939121D1 (de) Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden
DE60025170D1 (de) Diagnostisches verfahren für asthma
DE60332538D1 (de) Oligosaccharid-biomarker für mucopolysaccharidosen und andere verwandte störungen
US20090011452A1 (en) Method of Prognosis of Mental Diseases, E.G. Autism and Cerebral Palsy
EA199800493A1 (ru) Анализ крови на соотношение активности фактора v для оценки вероятности заболевания тромбоэмболией
WO2008007373B1 (en) Method and assay for glycosylation pattern detection related to cell state
KR20200085390A (ko) Ripk3을 포함하는 당뇨병성 신증 진단용 바이오마커 및 이의 용도
DE69941627D1 (de) Für krebs
TW200801515A (en) Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio- alzheimer's disease-specific molecular biomarkers (ADSMB)
WO2006113245B1 (en) Methods for measuring glycan levels of proteins
RU2008103988A (ru) Способ диагностики рассеяного склероза
EP1476757A4 (de) Verfahren und kit zur krebsvorhersage
KR101096487B1 (ko) 자폐증의 진단
ATE302947T1 (de) Verfahren zum nachweis eines lipoprotein- akutphaseprotein-komplexes
WO2007047029A3 (en) Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio as alzheimer's disease-specific molecular biomarkers (adsmb)
EP1376133A4 (de) Screening-verfahren für den prädiabetiszustand und screening-reagenz
KR20190080973A (ko) GTPase KRas 단백질(KRas)에 대한 SRM/MRM 검정
CA2366232A1 (en) Diagnosis of lysosomal storage disorders using saposins and other markers
WO2019169309A1 (en) Methods, apparatuses and kits for rapid testing of traumatic brain injuries
CA2586654A1 (en) Use of asc as a marker for colorectal cancer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties